Eugene

[email protected]

LATEST

Roche, Sarepta Sign $2.85-Bn Licensing Deal for Gene Therapy
By

By
Roche has signed a licensing agreement, worth up to $2.85 billion ($1.15 billion upfront), with Sarepta Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company, to provide Roche with exclusive commercial rights outside…

Sumitomo Dainippon, Roivant Sciences Complete $3-Bn Strategic Alliance
By

By
Sumitomo Dainippon Pharma and Roivant Sciences, a technology-enabled healthcare company, have completed a deal to form their previously announced strategic alliance and have formed a new company, Sumitovant Biopharma, in…

Amgen Acquires Equity Stake in BeiGene for $2.8 Bn; Forms Strategic Pact in China
By

By
Amgen has acquired an equity stake in BeiGene, a Beijing-based pharma company, for $2.8 billion and formed a strategic oncology-drug pact with BeiGene in China and globally. The companies had…

AbbVie Extends Exchange Offer Period in Pending $63-Bn Acquisition of Allergan
By

By
AbbVie has extended its exchange offer expiration date in its pending $63-billion acquisition of Allergan until January 31, 2020. The exchange offer period was scheduled to expire on December 31,…

AGC Biologics, Fujifilm Expand; AMRI Appoints New CEO
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from AGC Biologics, Avantor, Fujifilm, Sartorius, AMRI, Symbiosis and PCI Pharma. Biologics Manufacturing AGC Biologics To Expand Plasmid DNA Offering…

US Senate Confirms Dr. Stephen Hahn As Next FDA Commissioner
By

By
The US Senate has confirmed Dr. Stephen Hahn of MD Anderson Cancer Center to serve as the next Commissioner of the US Food and Drug Administration. The Senate confirmed Dr.…

Pfizer’ Executive Chairman Ian Read To Join Viatris Board; Retire from Pfizer Board
By

By
Pfizer announced that Ian Read, currently Pfizer’s Executive Chairman, will join the board of Viatris, the planned combination of Mylan, a generic-drug company, and Upjohn, Pfizer’s off-patent branded and generics…

US Gov’t Proposes to Allow Drug Importation from Canada, Other Countries
By

By
As part of a plan to lower the cost of prescription drugs, President Donald Trump, along with the US Department of Health and Human Services (HHS) and the US Food…

Global Pharma Briefs: News from Europe, Asia and the US
By

By
A roundup of developments and latest news from Germany (AstraZeneca, Cheplapharm), India (Sun Pharmaceuticals), United States (Amneal, Eli Lilly and Company, Sanofi). Germany AstraZeneca Completes Agreement with Cheplapharm for Seroquel…

US House of Representatives Passes Drug-Pricing Plan
By

By
The US House of Representatives has passed a proposed drug-pricing plan (H.R.3, Elijah E. Cummings Lower Drug Costs Now Act). The bill, which was first introduced in the House in…